| SKU | ISG017455 |
| Color | Luscious Blackberry |
| Imported Or Local | Special Import |
| UPC | 012345000 |
Olumiant 2 mg (Baricitinib) – 28 Film-Coated Tablets
Manage chronic inflammatory conditions with targeted precision using Olumiant 2 mg. Developed by Eli Lilly, Olumiant contains Baricitinib, a selective and reversible Janus kinase (JAK) inhibitor, focusing primarily on JAK1 and JAK2 subtypes. By dampening the intracellular signaling pathway responsible for cytokine production, this advanced, once-daily oral medication works from within to halt systemic inflammatory cascades that cause joint destruction, skin flare-ups, and autoimmune hair thinning.
Approved Therapeutic Indications:
- Rheumatoid Arthritis (RA): Indicated for the treatment of moderate-to-severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to, one or more disease-modifying antirheumatic drugs (DMARDs). Can be used as monotherapy or in combination with methotrexate.
- Alopecia Areata: Prescribed for adult patients suffering from severe alopecia areata to promote significant hair regrowth across the scalp, eyebrows, and eyelashes by calming the localized immune attack on hair follicles.
- Atopic Dermatitis (Eczema): Indicated for adult patients with moderate-to-severe atopic dermatitis who are candidates for systemic therapy, drastically reducing skin itchiness, redness, and lesions.
Mechanism of Action:
Cytokines play a central role in driving the systemic inflammation seen in autoimmune disorders. Olumiant works intracellularly by blocking specific Janus kinase enzymes ($JAK1$ and $JAK2$). These enzymes act as communication hubs; blocking them intercepts the signals that tell immune cells to attack healthy tissue. This results in decreased joint inflammation, repaired skin barriers, and protected hair follicles.
Suggested Dosage & Administration:
The standard recommended dose is one (1) 2 mg tablet taken once daily, with or without food, at the same time each day. Tablets must be swallowed whole and should not be crushed, split, or chewed. Your healthcare professional may adjust the dosage based on your age, renal function, or concurrent drug therapies.
Critical Safety Disclaimers & Precautions:
PRESCRIPTION-ONLY MEDICATION: Olumiant must only be used under strict medical supervision. Prior to initiating treatment, patients must be screened for active or latent tuberculosis (TB) and viral infections like Hepatitis B or C. Olumiant can lower the immune system's ability to fight infections. Avoid live vaccines during treatment. Consult your physician immediately if you experience signs of deep vein thrombosis (DVT), sudden shortness of breath, or unexplained fever.
Storage Instructions:
Store in the original blister pack below 30°C to protect from moisture. Keep out of the sight and reach of children.
